The Inherited Genetic Component of Sporadic Pancreatic Adenocarcinoma
暂无分享,去创建一个
N. Malats | F. Real | R. Milne | C. Murta-Nascimento | W. Greenhalf | Cristiane Murta-Nascimento | Francisco X. Real | Francisco X. Real
[1] Ying Wang,et al. Genomewide association study of leprosy. , 2009, The New England journal of medicine.
[2] M. McCarthy,et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges , 2008, Nature Reviews Genetics.
[3] Dieter Niederacher,et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. , 2008, American journal of human genetics.
[4] L. Tamer,et al. The association between N‐acetyltransferase 2 gene polymorphisms and pancreatic cancer , 2008, Cell biochemistry and function.
[5] D. Christiani,et al. Myeloperoxidase and superoxide dismutase polymorphisms are associated with an increased risk of developing pancreatic adenocarcinoma , 2008, Cancer.
[6] Manal M. Hassan,et al. XRCC2 and XRCC3 Gene Polymorphismand Risk of Pancreatic Cancer , 2008, The American Journal of Gastroenterology.
[7] P. Ruszniewski,et al. Risk of Pancreatic Adenocarcinoma in Patients With Hereditary Pancreatitis: A National Exhaustive Series , 2008, The American Journal of Gastroenterology.
[8] S. Chari,et al. Is autoimmune pancreatitis a risk factor for pancreatic cancer? , 2007, Pancreas.
[9] Franco Mosca,et al. Cancer Risk among the Relatives of Patients with Pancreatic Ductal Adenocarcinoma , 2007, Pancreatology.
[10] Xavier Estivill,et al. Copy Number Variants and Common Disorders: Filling the Gaps and Exploring Complexity in Genome-Wide Association Studies , 2007, PLoS genetics.
[11] Eithne Costello,et al. Biology and management of pancreatic cancer , 2007, Postgraduate Medical Journal.
[12] W. Bamlet,et al. Mitochondrial Genetic Polymorphisms and Pancreatic Cancer Risk , 2007, Cancer Epidemiology Biomarkers & Prevention.
[13] D. Gudbjartsson,et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.
[14] H. Friess,et al. HFE genotypes in patients with chronic pancreatitis and pancreatic adenocarcinoma , 2007, Genetics in Medicine.
[15] Lester L. Peters,et al. Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.
[16] Simon C. Potter,et al. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.
[17] Douglas B. Evans,et al. Aurora-A and p16 Polymorphisms Contribute to an Earlier Age at Diagnosis of Pancreatic Cancer in Caucasians , 2007, Clinical Cancer Research.
[18] P. Fearnhead,et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007, Nature Genetics.
[19] Manal M. Hassan,et al. Effects of base excision repair gene polymorphisms on pancreatic cancer survival , 2007, International journal of cancer.
[20] K. Christensen,et al. What genome-wide association studies can do for medicine. , 2007, The New England journal of medicine.
[21] Manal M. Hassan,et al. Glutathione S‐transferase gene polymorphisms and risk and survival of pancreatic cancer , 2007, Cancer.
[22] V. Beral,et al. Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis , 2007, British Journal of Cancer.
[23] Manal M. Hassan,et al. The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk. , 2007, Cancer letters.
[24] A. Zauber,et al. Allergies, variants in IL-4 and IL-4Rα genes, and risk of pancreatic cancer , 2007 .
[25] J. Izbicki,et al. Short tandem repeat polymorphisms of exon 4 in Kazal-type gene ECRG2 in pancreatic carcinoma and chronic pancreatitis. , 2007, Anticancer research.
[26] A. Jemal,et al. Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.
[27] A. Andriulli,et al. Lack of association between UGT1A7, UGT1A9, ARP, SPINK1 and CFTR gene polymorphisms and pancreatic cancer in Italian patients. , 2006, World journal of gastroenterology.
[28] F. Real,et al. Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer , 2006, Journal of Molecular Medicine.
[29] S. Larsson,et al. Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. , 2006, Gastroenterology.
[30] X. Miao,et al. [Polymorphisms of the DNA repair genes XRCC1 and XPC: relationship to pancreatic cancer risk]. , 2006, Wei sheng yan jiu = Journal of hygiene research.
[31] K. Hess,et al. Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] E. Holly,et al. Inflammation, Genetic Polymorphisms in Proinflammatory Genes TNF-A, RANTES, and CCR5, and Risk of Pancreatic Adenocarcinoma , 2006, Cancer Epidemiology Biomarkers & Prevention.
[33] Manal M. Hassan,et al. Significant effect of homologous recombination DNA repair gene polymorphisms on pancreatic cancer survival. , 2006, Cancer research.
[34] Manal M. Hassan,et al. Selected polymorphisms of DNA repair genes and risk of pancreatic cancer. , 2006, Cancer detection and prevention.
[35] Manal M. Hassan,et al. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. , 2006, Carcinogenesis.
[36] W. Greenhalf,et al. RNASEL germline variants are associated with pancreatic cancer , 2005, International journal of cancer.
[37] M. de Andrade,et al. Cystic fibrosis transmembrane regulator gene carrier status is a risk factor for young onset pancreatic adenocarcinoma , 2005, Gut.
[38] H. Friess,et al. Polymorphisms of UDP-glucuronosyltransferase 1A7 are not involved in pancreatic diseases , 2005, Journal of Medical Genetics.
[39] N. Malats,et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses , 2005, The Lancet.
[40] W. Tan,et al. Genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase and risk of pancreatic cancer. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[41] C. Iacobuzio-Donahue,et al. Pancreaticobiliary cancers with deficient methylenetetrahydrofolate reductase genotypes. , 2005, Clinical Gastroenterology and Hepatology.
[42] M. de Andrade,et al. Risk of malignancy in first‐degree relatives of patients with pancreatic carcinoma , 2005, Cancer.
[43] Manal M. Hassan,et al. 5,10-Methylenetetrahydrofolate Reductase Polymorphisms and the Risk of Pancreatic Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.
[44] Ireland,et al. Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. , 2005 .
[45] S Pancreatic,et al. Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas , 2005, Gut.
[46] H. Nevanlinna,et al. Mutations N34S and P55S of the SPINK1 gene in patients with chronic pancreatitis or pancreatic cancer and in healthy subjects: A report from Finland , 2005, Scandinavian journal of gastroenterology.
[47] F. Couch,et al. Germ line Fanconi anemia complementation group C mutations and pancreatic cancer. , 2005, Cancer research.
[48] K. Fearon,et al. Interferon-γ polymorphisms correlate with duration of survival in pancreatic cancer , 2004 .
[49] J. Peto,et al. The search for low-penetrance cancer susceptibility alleles , 2004, Oncogene.
[50] W. Greenhalf,et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[51] Lon R. Cardon,et al. The complex interplay among factors that influence allelic association , 2004, Nature Reviews Genetics.
[52] R. Bell,et al. International variation in pancreatic cancer mortality for the period 1955–1998 , 2002, European Journal of Epidemiology.
[53] Nathaniel Rothman,et al. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. , 2004, Journal of the National Cancer Institute.
[54] R. Hruban,et al. Polymorphisms of SPINK1 N34S and CFTR in Patients with Sporadic and Familial Pancreatic Cancer , 2003, Cancer biology & therapy.
[55] M. Manns,et al. UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. , 2003, Gastroenterology.
[56] A. Nouvenne,et al. Association of keratin 8 gene mutation with chronic pancreatitis. , 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[57] R. Hruban,et al. Fanconi anemia gene mutations in young-onset pancreatic cancer. , 2003, Cancer research.
[58] H. Witt,et al. N34S, a Pancreatitis Associated SPINK1 Mutation, Is Not Associated with Sporadic Pancreatic Cancer , 2003, Pancreatology.
[59] D. Botstein,et al. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease , 2003, Nature Genetics.
[60] A. Ziegler,et al. BRCA2 germline mutations in familial pancreatic carcinoma. , 2003, Journal of the National Cancer Institute.
[61] Douglas F Easton,et al. Cancer Incidence in BRCA1 mutation carriers. , 2002, Journal of the National Cancer Institute.
[62] E. Holly,et al. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. , 2002, Cancer research.
[63] T. Beaty,et al. Evidence for a major gene influencing risk of pancreatic cancer , 2002, Genetic epidemiology.
[64] Leonid Kruglyak,et al. A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34. , 2002, American journal of human genetics.
[65] E. Holly,et al. A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. , 2002, Journal of the National Cancer Institute.
[66] S. Kern,et al. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma–pancreatic carcinoma–prone families , 2002, Cancer.
[67] N. Lemoine,et al. Pancreatic Cancer Genetics , 2001, Pancreatology.
[68] R. Brand,et al. Hereditary Pancreatic Cancer , 2001, Pancreatology.
[69] N. Malats. Gene-Environment Interactions in Pancreatic Cancer , 2001, Pancreatology.
[70] W. Greenhalf,et al. Molecular Diagnosis of Early Pancreatic Ductal Adenocarcinoma in High-Risk Patients , 2001, Pancreatology.
[71] H. Blum,et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis , 2001, American Journal of Gastroenterology.
[72] J. Cameron,et al. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[73] X. Estivill,et al. Cystic fibrosis transmembrane regulator ( CFTR ) (cid:196) F508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer , 2000 .
[74] X. Estivill,et al. Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group. , 2001, Gut.
[75] S. Goodman,et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. , 2000, Gastroenterology.
[76] K. Fearon,et al. A polymorphism of the interleukin-1 β gene influences survival in pancreatic cancer , 2000, British Journal of Cancer.
[77] N. Gruis,et al. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16‐Leiden) , 2000, International journal of cancer.
[78] N. Risch. Searching for genetic determinants in the new millennium , 2000, Nature.
[79] W. Foulkes,et al. Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma , 2000, British Journal of Cancer.
[80] N. Malats,et al. Learning from case reports: diagnostic issues in an epidemiologic study of pancreatic cancer. , 1998, Journal of clinical epidemiology.
[81] P. Boyle,et al. Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk , 1998, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[82] J. Fraumeni,et al. Multiple primary cancers in families with Li-Fraumeni syndrome. , 1998, Journal of the National Cancer Institute.
[83] H. Lee,et al. Association Between Genetic Polymorphisms of the Cytochromes P-450 (1A1, 2D6, and 2E1) and the Susceptibility to Pancreatic Cancer , 1997, The Korean journal of internal medicine.
[84] T. Smyrk,et al. An update of HNPCC (Lynch syndrome). , 1997, Cancer genetics and cytogenetics.
[85] C. Moskaluk,et al. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. , 1996, Cancer research.
[86] C. la Vecchia,et al. Family history and the risk of liver, gallbladder, and pancreatic cancer. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[87] A. Swerdlow,et al. A cohort study of cystic fibrosis and malignancy. , 1993, British Journal of Cancer.
[88] F. Giardiello,et al. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. , 1993, Gut.
[89] A. Andrén-sandberg,et al. Pancreatitis and the risk of pancreatic cancer , 1993 .
[90] A. Andrén-sandberg,et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. , 1993, The New England journal of medicine.
[91] P. Boyle,et al. Reported family aggregation of pancreatic cancer within a population-based case-control study in the francophone community in Montreal, Canada , 1991, International journal of pancreatology : official journal of the International Association of Pancreatology.
[92] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[93] B. Terracini. Evaluation of Carcinogenic Risk of Chemicals to Man , 1972 .
[94] F. Mícek. [Cancer of the pancreas]. , 1965, Bratislavske lekarske listy.